IMNM Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Immunome Inc

Watchlist Manager

Watchlist

Price: 22.21 USD 0.91% Market Closed

Market Cap: $2.5B

	Immunome Inc NASDAQ:IMNM	US
C	Cal-Comp Electronics Thailand PCL SET:CCET	TH
A	Ace Hardware Indonesia Tbk PT F:4AH1	ID

Profitability Summary

Immunome Inc's profitability score is 7/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-5.948%

Negative 3Y Average Operating Margin

-1.580%

Declining Operating Margin

-401% > -5.948%

Negative Net Margin

-5.594%

Negative 3Y Average Net Margin

-2.201%

Declining Net Margin

-405% > -5.594%

Negative Free Cash Flow Margin

-5.343%

Negative 3Y Average Free Cash Flow Margin

-1.531%

Declining Free Cash Flow Margin

56% > -5.343%

Negative ROE

-50%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-7.256%

Declining ROIC

3.383% > -999%

View All

Hide

Collapse

7 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.